Classification of the Charcot neuroosteoarthropathy: evolution of views and unsolved problems

Diabetic Charcot neuroosteoarthropathy is a manifestation of diabetic foot syndrome, accompanied by a high risk of foot ulcers and amputation. Many aspects of this pathology due to its features remain poorly understood, which leads to difficulties in determining the tactics of treatment of these patients. This review analyzes of anatomical and functional classifications of Charcot foot. The review focuses on the midfoot pathology as the most severe in their consequences. The advantages and disadvantages of different approaches to the description of the X-ray picture of the disease at its various stages are analyzed. The systematization of the literature allows us to conclude that the existing approaches to classification are relatively acceptable mainly when planning conservative treatment. At the same time, detailed anatomical and radiological classifications do not help in choosing the tactics of reconstructive surgical treatment. With the increasing availability of reconstructive surgery for severe deformities due to Charcot’s arthropathy, it seems appropriate to develop classification systems that could become a practical tool for determining surgical tactics in this pathology.

1. Guidelines of International Working Group on Diabetic Foot: Charcot’s neuro-osteo-arthropathy (2023 update). Available from: https://iwgdfguidelines.org/charcot-2023

2. Harris JR, Brand PW. PATTERNS OF DISINTEGRATION OF THE TARSUS IN THE ANAESTHETIC FOOT. J Bone Joint Surg Br. 1966;48-B(1):4-16. doi: https://doi.org/10.1302/0301-620X.48B1.4

3. Sella EJ, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg. 1999;38:34-40. doi: https://doi.org/10.1016/s1067-2516(99)80086-6

4. Cofield RH, Morrison MJ, Beabout JW. Diabetic neuroarthropathy in the foot: patient characteristics and patterns of radiographic change. Foot Ankle. 1983;4:15-22. doi: https://doi.org/10.1177/107110078300400104

5. Sanders LJ, Frykberg RG. Diabetic neuropathic osteoarthropathy: The Charcot foot. In: Frykberg RG editor. The high risk foot in diabetes mellitus. New York: Churchill Livingstone. 1991:297−338

6. Gratwohl V, Jentzsch T, Schöni M, et al. Long-term follow-up of conservative treatment of Charcot feet. Arch Orthop Trauma Surg. 2022;142:2553-2566. doi: https://doi.org/10.1007/s00402-021-03881-5

7. Brodsky JW. The diabetic foot. In Mann R.A., Coughlin M. (ed): Surgery of the Foot and Ankle. St. Louis, C.V . Mosby. 1992

8. Brodsky JW, Rouse AM. Exostectomy for Symptomatic Bony Prominences in Diabetic Charcot Feet. Clin Orthop Relat Res. 1993;296:21-26. doi: https://doi.org/10.1097/00003086-199311000-00005

9. Trepman E, Nihal A, Pinzur MS. Current topics review: Charcot neuroarthropathy of the foot and ankle. Foot Ankle Int. 2005;26:46-63. doi: https://doi.org/10.1177/107110070502600109

10. Sammarco G, Conti S. Surgical treatment of neuroarthropathic foot deformity. Foot Ankle Int. 1998;19:102-109. doi: https://doi.org/10.1177/107110079801900209

11. Schon LC, Weinfeld SB, Horton GA, Resch S. Radiographic and clinical classification of acquired midtarsus deformities. Foot Ankle Int. 1998;19:394-404. doi: https://doi.org/10.1177/107110079801900610

12. Schon LC, Easley ME, Cohen I, et al. The acquired midtarsus deformity classification system-interobserver reliability and intraobserver reproducibility. Foot Ankle Int. 2002;23:30-36. doi: https://doi.org/10.1177/107110070202300106

13. Pinzur MS, Schiff AP. Deformity and clinical outcomes following operative correction of Charcot foot: A new classification with implications for treatment. Foot Ankle Int. 2018;39:265-270. doi: https://doi.org/10.1177/1071100717742371

14. Eichenholtz SN. Charcot joints. With a foreword by P.D. Wilson. Springfield (Ill): Charles C. Thomas. 1966.

15. Shibata T, Tada K, Hashizume C. The results of arthrodesis of the ankle for leprotic neuroarthropathy. J Bone Jt Surg. 1990;72(5):749-756. doi: https://doi.org/10.2106/00004623-199072050-00016

16. Chantelau E, Richter A. The acute diabetic Charcot foot managed on the basis of magnetic resonance imaging – a review of 71 cases. Swiss Med Wkly. 2013;143:w13831. Available at: https://smw.ch/article/doi/smw.2013.13831

17. Frykberg RG, Zgonis T, Armstrong DG, et al. American College of Foot and Ankle Surgeons. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45(5Suppl):S1-66. doi: https://doi.org/10.1016/S1067-2516(07)60001-5

18. Chantelau EA, Grutzner G. Is the Eichenholtz classification still valid for the diabetic Charcot foot? Swiss Med Wkly. 2014;144:1-6. doi: https://doi.org/10.4414/smw.2014.13948

19. Сахарный диабет 2 типа у взрослых. Клинические рекомендации. Доступно по: https://cr.minzdrav.gov.ru/schema/290_2. Ссылка активна на 30.11.23

20. Demina AG, Bregovskiy VB, Karpova IA. Criteria of immobilization duration of the affected foot in diabetic Charcot neuro-osteoarthropathy. Diabetes mellitus. 2014;4;60-65 (In Russ.). doi: https://doi.org/10.14341/DM2014460-65

21. Meacock L, Petrova NL, Donaldson A, et al. Novel semiquantitative bone marrow oedema score and fracture score for the magnetic resonance imaging assessment of the active Charcot foot in diabetes. Journal of Diabetes Research. 2017;8504137. doi: https://doi.org/10.1155/2017/8504137

22. Berli MC, Higashigaito K, Götschi T, et al. The «Balgrist Score» for evaluation of Charcot foot: a predictive value for duration of off-loading treatment. Skeletal Radiol. 2021;50:311-320. doi: https://doi.org/10.1007/s00256-020-03541-6

23. Chantelau EA, Antoniou S, Zweck B, Haage P. Follow up of MRI bone marrow edema in the treated diabetic Charcot foot — a review of patient charts. Diabet Foot Ankle. 2018;9:1466611. doi: https://doi.org/10.1080/2000625X.2018.1466611

24. Gooday C, Game F, Woodburn J, Poland F et al. A randomised feasibility study of serial magnetic resonance imaging to reduce treatment times in Charcot neuroarthropathy in people with diabetes (CADOM). J Foot Ankle Res. 2023;26:16(1):2. doi: https://doi.org/10.1186/s13047-023-00601-7

25. Obolenskiy VN, Protsko VG, Komeliagina EYu. K voprosu o klassifikacii syndroma diabeticheskoy stopi. Surgeon. 2016;10;37-47. (In Russ.).

26. Osnach SA, Obolenskiy VN, Protsko VG, et al. Method of two-stage treatment of total and subtotal defects of the foot in Charcot neuroosteoarthropathy. Genij Ortopedii. 2022;28;4:523-531. (In Russ.). doi: https://doi.org/1028-4427-2022-28-4-523-531

27. López-Moral M, Molines-Barroso RJ, Sanz-Corbalán I, et al. Predictive Radiographic Values for Foot Ulceration in Persons with Charcot Foot Divided by Lateral or Medial Midfoot Deformity. J Clin Med. 2022;18;11(3):474. doi: https://doi.org/10.3390/jcm11030474

28. Hastings MK, Sinacore DR, Mercer-Bolton N. Precision of foot alignment measures in Charcot arthropathy. Foot Ankle Int. 2011;32(9):867-872. doi: https://doi.org/10.3113/FAI.2011.0867